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KOVACIC ET AL: Ultrafiltration Volume is Associated with Changes in Blood Pressure in Chronically
Hemodialyzed Patients. Introduction: Volume overload is a main factor in development of hypertension in
hemodialysis patients. In order to demonstrate impact of ultrafiltration volume on blood pressure during 15-month
period in a group of patients undergoing chronic hemodialysis therapy, we conducted this study. We hypothezed that
ultrafiltration volume different affects the pre/postdialysis systolic pressure, diastolic pressure, mean arterial pressure
(MAP) and pulse pressure (PP) values. Subjects and Methods: Study subjects were 23 anuric chronically hemodialyzed
patients. The overall study time was 15 months, and 136 single hemodialysis treatments were analyzed. Results:
Ultrafiltration was negatively correlated with predialysis systolic blood pressure (r=-0.169, p=0.025), postdialysis
systolic blood pressure (r=-0.292, p<0.001), postdialysis MAP (r=-0.186, p=0.015), predialysis PP (r=-0.290,
p<0.001), and postdialysis PP (r=-0.370, p<0.001). Ultrafiltration/dry body mass (UF/W) ratio was negatively
correlated with predialysis PP (r=-0.222, p=0.005), postdialysis PP (r=-0.340, p<0.001), and postdialysis systolic
blood pressure (r=-0.243, p=0.002). We found significant difference in postdialysis PP between dialyses with UF/W
ratio ≤0.05 and dialyses with UF/W ratio >0.05 (63.49±20.76 vs. 56.27±16.33 mmHg, p=0.033). Conclusion: The
ultrafiltration volume strongly affects postdialysis PP values. Evaluation of elevated blood pressure treatment in
patients undergoing chronic hemodialysis therapy must be consider in respect of postdialysis PP values, not just
depending on pre/postdialysis systolic and diastolic pressure or MAP values. (J HK Coll Cardiol 2003;11:11-15)
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Introduction
Cardiovascular disease is the leading cause of
morbidity and mortality in end-stage renal disease.1
Hypertension is common and contributes to the high
cardiovascular morbidity in patients undergoing chronic
hemodialysis therapy.2
The impact of ultrafiltration and volume control
on hemodialysis blood pressure is a well known fact.3
Although hypertension in the hemodialysis patient
population is multifactorial, volume overload is a main
factor in the development of hypertension in hemodialysis patients.4
Definition of hypertension in patients undergoing
chronic hemodialysis therapy is still under debate.
Predialysis systolic and diastolic blood pressures are of
particular importance. Interdialytic ambulatory blood
pressure monitoring may help to determine if the patient
is in fact hypertensive. 5 The mean arterial pressure
(MAP) usually serves as expression of blood pressure
in hemodialysis patients, instead solely systolic or
diastolic blood pressure.
Investigations in the general population have
demonstrated pulse pressure (systolic minus diastolic
blood pressure) as a measure reflecting the pulsatile
nature of the cardiac cycle.6 Recent recognition revealed
pulse pressure (PP) as an important correlate of
mortality in patients receiving dialysis.7
In order to demonstrate impact of ultrafiltration
volume on pre/postdialysis blood pressure (systolic and
diastolic pressure, MAP and PP values) during 15month period in a group of patients undergoing chronic
hemodialysis therapy, we conducted this study. We
hypothesized that ultrafiltration volume differently
affects the pre/postdialysis systolic pressure, diastolic
pressure, MAP and PP values.

Subjects and Methods
Study subjects were 23 anuric chronically
hemodialyzed patients (11 males and 12 females) on
three-time-per-week dialysis regime, with history of
chronic hemodialysis treatment for at least one year
(mean hemodialysis treatment period was 5.09±3.59
years). Fifteen subjects suffered from chronic
glomerulonephritis, 5 from chronic pyelonephritis and
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3 subjects had diabetic nephropathy. Three subjects had
insulin-dependent diabetes mellitus. Twenty subjects
were treated with erythropoietin (mean weekly dose was
3622±1856 IU). Clinical characteristic of the subjects
are demonstrated on Table 1.
Overall study time was 15 months. Outcomes
were measured on the study beginning and at three
months intervals; six measurements per subject were
totally conducted.
Antihypertensive drugs used were ACE inhibitors
(3 subjects), calcium antagonists (2 subjects) and beta
blockers (2 subjects).
Primary outcome measures for every single
observed hemodialysis (HD) were: systolic and diastolic
blood pressure before and after hemodialysis treatment
(mmHg), and ultrafiltration (L).
Secondary outcome measures were predialysis
and postdialysis mean arterial pressure (MAP)
calculated as (systolic +2 diastolic blood pressure)/
3 (mmHg), predialysis and postdialysis pulse pressure
(PP) computed as (systolic-diastolic blood pressure)
(mmHg), and ultrafiltration volume/dry body mass (UF/
W) ratio (L/kg). Differences between predialysis and
postdialysis systolic, diastolic, MAP, and PP values for

Table 1. Clinical characteristic of the subjects (n=23)
on the study beginning
Age (years)
PCR (g/kg/day)
Kt/V Daugirdas 2. generation
Calcium (mmol/L)
Phosphorus (mmol/L)
Creatinine (µmol/L)
Hemoglobin (g/L)
Urea (mmol/L)
Albumins (g/L)
Total cholesterol (mmol/L)
LDL-cholesterol (mmol/L)
HDL-cholesterol (mmol/L)
Triglycerides (mmol/L)
BMI (kg/m2)

60.75±10.92
0.98±0.34
1.22±0.28
2.58±0.24
1.60±0.50
1258.82±18.31
110.32±13.59
25.77±5.82
39.25±5.57
5.11±0.94
3.00±0.99
1.28±0.44
2.22±0.93
25.38±3.14

Legend: LDL: low-density lipoproteins; HDL: high-density lipoproteins,
BMI: body mass index, Kt/V single dialysis efficiency (for all 136
treatment), PCR: protein catabolic rate.
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every single observed hemodialysis were also calculated
(delta values).
The duration of single hemodialysis treatment
was 3.5-5 hours, mean heparinisation dose was
4950±1282.17 IU. Temperature of the dialysis bath was
35.5-36.6°C, and the dialysis bath consisted of:
bicarbonate 32-35, sodium 138-145, potassium 2, and
calcium 1.25-1.75 mmol/L. The subjects were dialyzed
on low flux polysulphone dialyzers F6 and F8
(Fresenius, Bad Homburg, Germany). All subjects had
Cimino fistula as blood access.
No subject dropped out from the study. During
the study period, medication and dialysis conditions for
the same subject were unchanged. If the prescribed
conditions during dialysis treatment or medication were
changed, that dialysis session was not included in the
study. Two dialysis processes dropped out, so 136
dialyses were included in the investigation.
Blood pressure was measured with mercury
column sphygmomanometer by trained clinicians,
just before beginning of the hemodialysis treatment
and just after the end of the same dialysis treatment
in recumbent subject. Disappearance of bruits
(Korotkoff phase V) identified diastolic blood
pressure. Ultrafiltration was measured volumetrically
on the dialysis machine.
The results were expressed as arithmetic mean
± standard deviation. Normality of distribution was
tested with the Shapiro-Wilk's W test. Differences
between two dialysis groups were calculated by
Student's t tests for dependent and independent data,
respectively. Correlations between variables were
tested by Pearson correlation coefficients and linear
regression analysis.
A p value of less than 0.05 was considered
statistically significant.

Results
Data from 136 single dialysis treatments were
processed. Differences between predialysis vs.
postdialysis systolic blood pressure, diastolic blood
pressure, mean arterial pressure (MAP), and pulse
pressure (PP) with significances are demonstrated on
Table 2.
Pearson's correlations between blood all pressure
parameters and ultrafiltration (UF) and ultrafiltration/
dry body mass ratio (UF/W) were performed.
We found that UF was negatively correlated with
predialysis systolic blood pressure (r=-0.169, p=0.025),
postdialysis systolic blood pressure (r=-0.292, p<0.001),
postdialysis MAP (r=-0.186, p=0.015), predialysis PP
(r=-0.290, p<0.001), postdialysis PP (r=-0.370,
p<0.001); and positively correlated with delta MAP
(r=0.17, p=0.045). We found that UF/W ratio was
negatively correlated with predialysis PP (r=-0.222,
p=0.005), postdialysis PP (r=-0.340, p<0.001), and
postdialysis systolic blood pressure (r=-0.243, p=0.002).
Linear regression plot between postdialysis pulse
pressure (PP) and ultrafiltration volume per
hemodialysis is depicted on Figure 1.
We also tested differences in blood pressure
parameters (predialysis, postdialysis and delta values
of systolic pressure, diastolic pressure, MAP, and PP)
between two groups of dialyses: dialyses with UF/W
ratio ≤0.05 and dialyses with UF/W ratio >0.05. The
value of UF/W ratio >0.05 means that total amount of
ultrafiltration volume represents more than 5% of body
mass. That percent defines high ultrafiltration rate
hemodialysis.8 We found significant difference between
dialyses with UF/W ratio ≤0.05 and dialyses with UF/
W ratio >0.05 only in postdialysis PP (63.49±20.76 vs.
56.27±16.33 mmHg, p=0.033, two-tailed).

Table 2. Differences between predialysis vs. postdialysis systolic blood pressure, diastolic blood pressure,
mean arterial pressure, and pulse pressure with significances (p) (Student t test for dependent data)
Systolic blood pressure (mmHg)
Diastolic blood pressure (mmHg)
Mean arterial pressure (mmHg)
Pulse pressure (mmHg)
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Predialysis
144.92±26.91
79.41±14.74
101.24±17.50
65.51±19.00
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Postdialysis
134.10±27.49
73.55±14.34
93.73±17.49
60.55±19.35

Significances
p<0.001
p<0.001
p<0.001
p=0.002
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Figure 1. Linear regression plot between postdialysis pulse pressure (PP) and ultrafiltration
per hemodialysis (HD).

Discussion
Arterial hypertension is frequent among
chronically dialyzed patients. In dialysis patients the
chronic fluid overload may represent a nonphysiologic
condition, which brings both arterial hypertension and
hemodynamic instability.4
Our data confirmed our assumption of different
influence of ultrafiltration volume on blood pressure
parameters in dialysis patients. Changes in the
ultrafiltration volume affected mostly systolic
postdialysis blood pressure and consequently, pulse
pressure (PP). We demonstrate the most significant
influence of ultrafiltration volume on the postdialysis
PP. Diastolic blood pressure was not affected with
ultrafiltration volume, neither predialysis nor
postdialysis.
Prakash et al.9 demonstrated positive correlation of
volume overload with predialysis MAP. Ozkahya et al.10
displayed good blood pressure control (systolic an
diastolic) with ultrafiltration, after cessation of anti-
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hypertensive drugs. On the contrary, Testa et al.11 could
not demonstrate influence of volume overload on
systolic and diastolic blood pressure in patients
undergoing chronic hemodialysis therapy. Luik et al.12
also concluded that interdialytic fluid load does not
result in higher blood pressure (interdialytic blood
pressure was measured with an ambulatory blood
pressure monitor) in hemodialysis patients. Expansion
of extracellular fluid volume is the major pathophysiologic mechanism for the development of
hypertension in these patients; however, alterations in
other humoral mechanisms (especially nitric oxide and
endothelin 1 disbalance) also play a significant role.13,14
Although various factors influence the
pathogenesis of hypertension, volume overload is the
most significant. The normalization of the patient
hydration status is followed by a reduction in pressure
values. 15 Fluid removal is usually achieved by
ultrafiltration to achieve a clinically derived value for
"dry weight."16 The achievement of an optimal dry
weight is still one of the most difficult and important
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tasks of a dialysis clinic.17 Covic et al.18 concluded that
24-hour blood pressure and blood pressure after dialysis
are better related to total body water than blood pressure
before dialysis, which was however weakly related to
the acute volume overload, induced by interdialytic
weight gain. In some hypertensive hemodialysis
patients, blood pressure rises further during ultrafiltration. Cirit et al.19 concluded that the paradoxical
blood pressure rise with ultrafiltration usually occurs
in the presence of overhydration and cardiac dilatation
and should be treated by intensified ultrafiltration. The
explanation of this phenomenon remains speculative.
Finally, our findings support our assumption that
amount of ultrafiltration volume affects different blood
pressure clinical parameters. The ultrafiltration volume
strongly affects postdialysis PP values. Treatment of
arterial hypertension in dialyzed patients depends
mostly on ultrafiltration volume removal and real dry
weight achievement.20,21 Consequently, evaluation of
elevated blood pressure treatment in patients undergoing
chronic hemodialysis therapy must be considered in
respect of postdialysis PP values, not just depending
on pre/postdialysis systolic and diastolic pressure or
MAP values. We recommend postdialysis PP values as
a marker of ultrafiltration treatment and blood pressure
control parameter.
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